Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Crofelemer

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,823Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jaguar Health Strengthens Global IP With New Crofelemer Patent
    Jaguar Health Strengthens Global IP With New Crofelemer Patent

    24 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-24/jaguar-health-secures-new-patent-for-crofelemer-in-short-bowel-syndrome-strengthening-global-ip-pos

    PHARMIWEB
    24 Nov 2025
    Share Share
    Jaguar Health Submits Amended Protocol To FDA For Crofelemer
    Jaguar Health Submits Amended Protocol To FDA For Crofelemer

    20 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-20/in-support-of-possible-expedited-approval-pathway-for-crofelemer-for-treatment-of-microvillus-inclus

    PHARMIWEB
    20 Nov 2025
    Share Share
    Jaguar Health Reports 4% Revenue Growth In Q3 2025
    Jaguar Health Reports 4% Revenue Growth In Q3 2025

    17 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-17/jaguar-health-reports-third-quarter-2025-financials-net-q3-2025-revenue-up-approximately-4-versus

    PHARMIWEB
    17 Nov 2025
    Share Share
    Jaguar Health Provides Recap of November 8, 2025 Presentation
    Jaguar Health Provides Recap of November 8, 2025 Presentation

    13 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-13/jaguar-health-provides-recap-of-november-8-2025-presentation-on-groundbreaking-results-of-proof-of

    PHARMIWEB
    13 Nov 2025
    Share Share
    Jaguar Health Unveils Crofelemer for Pediatric Intestinal Failure
    Jaguar Health Unveils Crofelemer for Pediatric Intestinal Failure

    06 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-06/reminder-initial-groundbreaking-results-of-proof-of-concept-study-of-jaguar-healths-crofelemer-for

    PHARMIWEB
    06 Nov 2025
    Share Share
    Jaguar Health Meets FDA To Advance Crofelemer Trial
    Jaguar Health Meets FDA To Advance Crofelemer Trial

    06 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-06/jaguar-health-completes-meeting-with-fda-for-advice-on-development-pathways-to-advance-ongoing-crofe

    PHARMIWEB
    06 Oct 2025
    Share Share